Recursion Provides Updated Guidance on Clinical Trial Starts
Go back to Recursion Provides Updated Guidance on Clinical Trial Starts| (NASDAQ: RXRX) | Delayed: 3.47 -0.16 (4.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.63 | 52 Week High | $ | |||
| Open | $3.58 | 52 Week Low | $ | |||
| Day High | $3.59 | P/E | N/A | |||
| Day Low | $3.46 | EPS | $ | |||
| Volume | 6,774,175 | |||||
